Goldman Sachs’s ALEXZA PHARMACEUTICALS INC COM STK NEW (DE) ALXA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-432,822
| Closed | -$210K | – | 4757 |
|
|
2016
Q1 | $210K | Buy |
432,822
+30,058
| +7% | +$14.6K | ﹤0.01% | 3747 |
|
|
2015
Q4 | $282K | Sell |
402,764
-419
| -0.1% | -$293 | ﹤0.01% | 3545 |
|
|
2015
Q3 | $496K | Sell |
403,183
-9,357
| -2% | -$11.5K | ﹤0.01% | 3311 |
|
|
2015
Q2 | $450K | Sell |
412,540
-59,947
| -13% | -$65.4K | ﹤0.01% | 3417 |
|
|
2015
Q1 | $978K | Sell |
472,487
-34
| -0% | -$70 | ﹤0.01% | 2931 |
|
|
2014
Q4 | $704K | Sell |
472,521
-13,613
| -3% | -$20.3K | ﹤0.01% | 3152 |
|
|
2014
Q3 | $1.13M | Sell |
486,134
-495
| -0.1% | -$1.15K | ﹤0.01% | 2826 |
|
|
2014
Q2 | $2.22M | Buy |
486,629
+28,935
| +6% | +$132K | ﹤0.01% | 2488 |
|
|
2014
Q1 | $2.03M | Sell |
457,694
-11,260
| -2% | -$49.9K | ﹤0.01% | 2541 |
|
|
2013
Q4 | $2.22M | Buy |
468,954
+394,434
| +529% | +$1.87M | ﹤0.01% | 2567 |
|
|
2013
Q3 | $382K | Sell |
74,520
-2,399
| -3% | -$12.3K | ﹤0.01% | 3477 |
|
|
2013
Q2 | $334K | Buy |
+76,919
| New | +$334K | ﹤0.01% | 3393 |
|